Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-03-31
DOI
10.3389/fphar.2016.00088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease
- (2018) Karine Madsen et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study
- (2018) Lutz Frölich et al. JOURNAL OF ALZHEIMERS DISEASE
- A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
- (2018) Wei Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- PET Imaging of Neuropathology in Tauopathies: Progressive Supranuclear Palsy
- (2018) Vladimir Kepe et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors
- (2018) Taher Darreh-Shori et al. JOURNAL OF ALZHEIMERS DISEASE
- Plaque Deposition Dependent Decrease in 5-HT2A Serotonin Receptor in AβPPswe/PS1dE9 Amyloid Overexpressing Mice
- (2017) Peter Holm et al. JOURNAL OF ALZHEIMERS DISEASE
- Phenserine Efficacy in Alzheimer's Disease
- (2017) Bengt Winblad et al. JOURNAL OF ALZHEIMERS DISEASE
- Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
- (2016) Bieneke Janssen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
- (2016) Mudasir Maqbool et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease
- (2016) Madhuri Venigalla et al. NEUROCHEMISTRY INTERNATIONAL
- Oleocanthal Enhances Amyloid-β Clearance from the Brains of TgSwDI Mice and in Vitro across a Human Blood-Brain Barrier Model
- (2015) Hisham Qosa et al. ACS Chemical Neuroscience
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions
- (2015) James Varley et al. Alzheimers & Dementia
- Translocator protein: pharmacology and steroidogenesis
- (2015) Andrew Midzak et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease
- (2015) Antigoni Ekonomou et al. BIOLOGICAL PSYCHIATRY
- PET tracers for imaging brain α7 nicotinic receptors: an update
- (2015) S. Chalon et al. CHEMICAL COMMUNICATIONS
- Role of Semiquantitative Assessment of Regional Binding Potential in 123I-FP-CIT SPECT for the Differentiation of Frontotemporal Dementia, Dementia With Lewy Bodies, and Alzheimer’s Dementia
- (2015) Timo S. Spehl et al. CLINICAL NUCLEAR MEDICINE
- Tau imaging in neurodegenerative diseases
- (2015) M. Dani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The role of positron emission tomography imaging in understanding Alzheimer’s disease
- (2015) Henryk Barthel et al. Expert Review of Neurotherapeutics
- Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature
- (2015) Michaela Defrancesco et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Monoamine oxidase: radiotracer chemistry and human studies
- (2015) Joanna S. Fowler et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Imaging of neuroinflammation in dementia: a review
- (2015) James Stefaniak et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Biomarkers in the diagnosis and management of Alzheimer’s disease
- (2015) Richard Wurtman METABOLISM-CLINICAL AND EXPERIMENTAL
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- The role of positron emission tomography imaging in understanding Alzheimer’s disease
- (2015) Henryk Barthel et al. Expert Review of Neurotherapeutics
- PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
- (2015) Olga G. James et al. Frontiers in Neurology
- Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography
- (2015) Aiko Ishiki et al. PLoS One
- Biological markers of Alzheimer?s disease
- (2014) Leonardo Cruz de Souza et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET
- (2014) Nobuyuki Okamura et al. BRAIN
- Developments in Tau PET Imaging
- (2014) Eduardo Rigon Zimmer et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- PET Radioligands for In Vivo Visualization of Neuroinflammation
- (2014) Dieter Ory et al. CURRENT PHARMACEUTICAL DESIGN
- Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives
- (2014) Maria Polidori et al. CURRENT PHARMACEUTICAL DESIGN
- In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
- (2014) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients
- (2014) IL Han Choo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The translocator protein as a drug target in Alzheimer’s disease
- (2014) Sook W Chua et al. Expert Review of Neurotherapeutics
- Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
- (2014) William James Deardorff et al. Expert Review of Neurotherapeutics
- Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography
- (2014) Chloe Clark-Papasavas et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
- (2014) Sun-Ho Han et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Biomarkers in dementia: clinical utility and new directions
- (2014) R M Ahmed et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers
- (2014) M. Shah et al. JOURNAL OF NUCLEAR MEDICINE
- Different patterns of brain activation in normal aging and Alzheimer's disease from cognitional sight: meta analysis using activation likelihood estimation
- (2014) Saeed Sadigh-Eteghad et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer’s disease (Review)
- (2014) ZHIYOU CAI Molecular Medicine Reports
- Immunotherapy for Alzheimer’s disease: past, present and future
- (2014) Brian Spencer et al. Frontiers in Aging Neuroscience
- “Is dopamine involved in Alzheimer's disease?â€
- (2014) Alessandro Martorana et al. Frontiers in Aging Neuroscience
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings
- (2013) Gary W. Small et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer’s aetiopathology
- (2013) Hiroyuki Okada et al. BRAIN
- PET Radiotracers for Molecular Imaging of Serotonin 5-HT1A Receptors
- (2013) T. Billard et al. CURRENT MEDICINAL CHEMISTRY
- The interest of amyloid PET imaging in the diagnosis of Alzheimerʼs disease
- (2013) Rik Vandenberghe et al. CURRENT OPINION IN NEUROLOGY
- Phase II Crossover Trial of Varenicline in Mild-to-Moderate Alzheimer's Disease
- (2013) Seong Yoon Kim et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Aripiprazole in the treatment of Alzheimer's disease
- (2013) Peter Paul De Deyn et al. EXPERT OPINION ON PHARMACOTHERAPY
- PET radioligands targeting the brain GABAA/benzodiazepine receptor complex
- (2013) Jan D. Andersson et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- The potential of carbon-11 and fluorine-18 chemistry: illustration through the development of positron emission tomography radioligands targeting the translocator protein 18 kDa
- (2013) Annelaure Damont et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for -Amyloid Imaging in Aging and Dementia
- (2013) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Immunotherapy for Alzheimer’s disease: hoops and hurdles
- (2013) Cynthia A Lemere Molecular Neurodegeneration
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care
- (2013) Ludwig Trillo et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments
- (2013) Margaret K. King et al. PHARMACOLOGY & THERAPEUTICS
- New Molecular Targets for PET and SPECT Imaging in Neurodegenerative Diseases
- (2013) Marcel Benadiba et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Disease-modifying drugs in Alzheimer's disease
- (2013) Elio Scarpini et al. Drug Design Development and Therapy
- Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
- (2013) Moussa B.H. Youdim Experimental Neurobiology
- Advances in PET Imaging of P-Glycoprotein Function at the Blood-Brain Barrier
- (2012) Stina Syvänen et al. ACS Chemical Neuroscience
- National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
- (2012) Bradley T. Hyman et al. Alzheimers & Dementia
- Recent Development of Radioligands for Imaging α7 Nicotinic Acetylcholine Receptors in the Brain
- (2012) Jun Toyohara et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- γ-Aminobutyric Acid Type A (GABAA) Receptor Activation Modulates Tau Phosphorylation
- (2012) Niko-Petteri Nykänen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines
- (2012) Stefan Berg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease
- (2012) Ling Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Evidence for Astrocytosis in Prodromal Alzheimer Disease Provided by 11C-Deuterium-L-Deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG
- (2012) S. F. Carter et al. JOURNAL OF NUCLEAR MEDICINE
- Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease
- (2012) K. Guzman-Ramos et al. LEARNING & MEMORY
- From Antioxidant Chelators to Site-Activated Multi-Target Chelators Targeting Hypoxia Inducing Factor, Beta-Amyloid, Acetylcholinesterase and Monoamine Oxidase A/B
- (2012) H. Zheng et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients
- (2012) Alessandro Martorana et al. NEUROPHARMACOLOGY
- Brain Amyloid Imaging — FDA Approval of Florbetapir F18 Injection
- (2012) Lucie Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- [11C]flumazenil Binding Is Increased in a Dose-Dependent Manner with Tiagabine-Induced Elevations in GABA Levels
- (2012) W. Gordon Frankle et al. PLoS One
- Loss of functional GABAA receptors in the Alzheimer diseased brain
- (2012) A. Limon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
- (2012) Yunqi Xu et al. PROGRESS IN NEUROBIOLOGY
- The serotonergic system in ageing and Alzheimer's disease
- (2012) José Julio Rodríguez et al. PROGRESS IN NEUROBIOLOGY
- Current and future treatments for Alzheimer’s disease
- (2012) Konstantina G. Yiannopoulou et al. Therapeutic Advances in Neurological Disorders
- Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh compound B units of brain Aβ amyloid
- (2011) Stephen D. Weigand et al. Alzheimers & Dementia
- Efficacy and Tolerability of Antidepressants in the Treatment of Behavioral and Psychological Symptoms of Dementia, A Literature Review of Evidence
- (2011) Genevieve Henry et al. American Journal of Alzheimers Disease and Other Dementias
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Positron Emission Tomography of Brain β-Amyloid and Tau Levels in Adults With Down Syndrome
- (2011) Linda D. Nelson et al. ARCHIVES OF NEUROLOGY
- Chaperoning α7 neuronal nicotinic acetylcholine receptors
- (2011) Ana S. Vallés et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
- (2011) Patrizia Mecocci et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease
- (2011) M. T. Fodero-Tavoletti et al. BRAIN
- Role of Serotonin in Alzheimerʼs Disease
- (2011) Werner J. Geldenhuys et al. CNS DRUGS
- γ-Secretase Inhibitors and Modulators for the Treatment of Alzheimer's Disease: Disappointments and Hopes
- (2011) Bruno P. Imbimbo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Advances in tau-based drug discovery
- (2011) Wendy Noble et al. Expert Opinion on Drug Discovery
- A small cytoplasmic region adjacent to the fourth transmembrane segment of the α7 nicotinic receptor is essential for its biogenesis
- (2011) Manuel Criado et al. FEBS LETTERS
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
- (2011) David R Owen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
- (2011) V. L. Villemagne et al. JOURNAL OF NUCLEAR MEDICINE
- Alzheimer's disease
- (2011) Clive Ballard et al. LANCET
- 5-HT radioligands for human brain imaging with PET and SPECT
- (2011) Louise M. Paterson et al. MEDICINAL RESEARCH REVIEWS
- GSK-3α/β kinases and amyloid production in vivo
- (2011) Tomasz Jaworski et al. NATURE
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- A phase II trial of huperzine A in mild to moderate Alzheimer disease
- (2011) M. S. Rafii et al. NEUROLOGY
- Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTP
- (2011) Laura Ravasi et al. NUCLEAR MEDICINE AND BIOLOGY
- Alzheimer's Disease: Aging, Insomnia and Epigenetics
- (2011) Tzong Yuan Wu et al. Taiwanese Journal of Obstetrics & Gynecology
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- Methylphenidate for Apathy and Functional Status in Dementia of the Alzheimer Type
- (2010) Prasad R. Padala et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- The history of the cholinergic hypothesis
- (2010) Antonio Contestabile BEHAVIOURAL BRAIN RESEARCH
- Management of Neuropsychiatric Symptoms in People with Dementia
- (2010) Clive Ballard et al. CNS DRUGS
- The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease
- (2010) Robert A. Mitchell et al. CNS Neuroscience & Therapeutics
- Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimers Disease
- (2010) G. Maher-Edwards et al. Current Alzheimer Research
- β -Amyloid: A Disease Target or a Synaptic Regulator Affecting Age-Related Neurotransmitter Changes?
- (2010) E. Mura et al. CURRENT PHARMACEUTICAL DESIGN
- SPECT imaging of GABAA/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment
- (2010) Sabina Pappatà et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography
- (2010) Kai Kendziorra et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The selective 5-HT1A receptor antagonist NAD-299 increases acetylcholine release but not extracellular glutamate levels in the frontal cortex and hippocampus of awake rat
- (2010) Jan Kehr et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Serotonergic Facilitation of Acetylcholine Release In Vivo from Rat Dorsal Hippocampus via Serotonin 5-HT3 Receptors
- (2010) Silvana Console et al. JOURNAL OF NEUROCHEMISTRY
- Loss of 7 Nicotinic Receptors Enhances -Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease
- (2010) C. M. Hernandez et al. JOURNAL OF NEUROSCIENCE
- A randomized double-blind study comparing 25 and 50 mg TC-1734 (AZD3480) with placebo, in older subjects with age-associated memory impairment
- (2010) Geoffrey C Dunbar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study
- (2010) Lisbeth Marner et al. NEUROBIOLOGY OF AGING
- Tau protein and tau aggregation inhibitors
- (2010) Bruno Bulic et al. NEUROPHARMACOLOGY
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Variation in binding affinity of the novel anxiolytic XBD173 for the 18 kDa translocator protein in human brain
- (2010) David R.J. Owen et al. SYNAPSE
- Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history
- (2010) Streit Frontiers in Aging Neuroscience
- Drug development for Alzheimer's disease: Where are we now and where are we headed?
- (2009) Marwan N. Sabbagh American Journal Geriatric Pharmacotherapy
- Development of Tau Aggregation Inhibitors for Alzheimer's Disease
- (2009) Bruno Bulic et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Extrapyramidal Signs Before and After Diagnosis of Incident Alzheimer Disease in a Prospective Population Study
- (2009) Florence Portet et al. ARCHIVES OF NEUROLOGY
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
- (2009) Clifford R. Jack et al. BRAIN
- PET of Brain Prion Protein Amyloid in Gerstmann-Sträussler-Scheinker Disease
- (2009) Vladimir Kepe et al. BRAIN PATHOLOGY
- Assessment of MAO-B Occupancy in the Brain With PET and [11C]-L-Deprenyl-D2: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301
- (2009) J Hirvonen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Addressing Alzheimers Disease Tangles: From NAP to AL-108
- (2009) Illana Gozes et al. Current Alzheimer Research
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Methylphenidate for the Treatment of Apathy in Alzheimer Disease
- (2009) Nathan Herrmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease
- (2009) Y. Ouchi et al. JOURNAL OF NUCLEAR MEDICINE
- Standards for PET Image Acquisition and Quantitative Data Analysis
- (2009) R. Boellaard JOURNAL OF NUCLEAR MEDICINE
- Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding
- (2009) N. Tolboom et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of 18F-FDG and PiB PET in Cognitive Impairment
- (2009) V. J. Lowe et al. JOURNAL OF NUCLEAR MEDICINE
- A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease
- (2009) Shirley W. Tsang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
- (2009) S. Reeves et al. NEUROLOGY
- Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
- (2009) A. Okello et al. NEUROLOGY
- PET versus SPECT: strengths, limitations and challenges
- (2009) Arman Rahmim et al. NUCLEAR MEDICINE COMMUNICATIONS
- Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection
- (2009) S. D. Buckingham et al. PHARMACOLOGICAL REVIEWS
- Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer's disease with [18F]deuteroaltanserin and PET
- (2009) Lekshmi Santhosh et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
- (2009) Rainer Rupprecht et al. SCIENCE
- Monoamine oxidase inactivation: From pathophysiology to therapeutics☆
- (2008) Marco Bortolato et al. ADVANCED DRUG DELIVERY REVIEWS
- Optimizing phase II of drug development for disease-modifying compounds
- (2008) Jeffrey L. Cummings Alzheimers & Dementia
- The amyloid cascade hypothesis
- (2008) Amos D. Korczyn Alzheimers & Dementia
- Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
- (2008) Ludovico Minati et al. American Journal of Alzheimers Disease and Other Dementias
- Apathy Associated with Alzheimer Disease: Use of Dextroamphetamine Challenge
- (2008) Krista L. Lanctôt et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia
- (2008) Gil D. Rabinovici et al. ANNALS OF NEUROLOGY
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
- Function and structure of inherently disordered proteins
- (2008) A Keith Dunker et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Acetylcholine receptors in dementia and mild cognitive impairment
- (2008) Osama Sabri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies
- (2008) Sean J. Colloby et al. INTERNATIONAL PSYCHOGERIATRICS
- Molecular characterization and localization of the RIC-3 protein, an effector of nicotinic acetylcholine receptor expression
- (2008) Francisco Castelán et al. JOURNAL OF NEUROCHEMISTRY
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
- Aggregator compounds confound amyloid fibrillization assay
- (2008) Gilbert M Rishton Nature Chemical Biology
- Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer’s disease
- (2008) Oliver Ambrée et al. NEUROBIOLOGY OF AGING
- Relationship between nicotinic receptors and cognitive function in early Alzheimer’s disease: A 2-[18F]fluoro-A-85380 PET study
- (2008) J.R. Ellis et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease
- (2008) L. Truchot et al. NEUROIMAGE
- Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
- (2008) M. Cosenza-Nashat et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
- (2008) V.L. Villemagne et al. NEUROPSYCHOLOGIA
- Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects
- (2008) W Gordon Frankle et al. NEUROPSYCHOPHARMACOLOGY
- Serotonin type 3 receptor genes:HTR3A, B, C, D, E
- (2008) Beate Niesler et al. PHARMACOGENOMICS
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
- Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels
- (2007) R. Christensen et al. EXPERIMENTAL NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now